Spruce Biosciences, Inc. (SPRB)

NASDAQ: SPRB · Real-Time Price · USD

63.40

+4.75 (8.10%)

At close: Aug 25, 2026, 4:00 PM EDT

64.51

+1.11 (1.75%)

After-hours: Aug 25, 2026, 7:52 PM EDT

Spruce Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	96.3	48.91	38.75	96.34	24.49	42.75
Short-Term Investments	-	-	-	-	54.59	46.22
Cash & Short-Term Investments	96.3	48.91	38.75	96.34	79.08	88.97
Cash Growth	487.63%	26.20%	-59.77%	21.83%	-11.12%	-43.39%
Other Receivables	-	2.6	-	-	-	-
Receivables	-	2.6	-	-	-	-
Prepaid Expenses	4.63	0.35	3.18	3.88	3.32	2.53
Restricted Cash	-	-	-	-	0.22	-
Other Current Assets	0.23	0.25	2.28	1.97	1	0.4
Total Current Assets	101.15	52.11	44.21	102.18	83.61	91.9
Property, Plant & Equipment	0.52	0.67	0.93	1.18	1.4	1.48
Long-Term Investments	-	-	-	-	-	32.46
Other Long-Term Assets	1.18	0.24	0.07	0.58	0.64	0.65
Total Assets	102.85	53.02	45.21	103.95	85.65	126.49

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	1.21	0.94	1.3	3.33	1.43	2.82
Accrued Expenses	6.92	8.83	12.05	14.35	9.26	5.69
Current Portion of Long-Term Debt	2.5	-	1.62	1.62	1.62	-
Current Portion of Leases	0.34	0.32	0.28	0.25	0.14	0.36
Current Unearned Revenue	-	-	-	4.91	-	-
Total Current Liabilities	10.96	10.09	15.25	24.47	12.45	8.87
Long-Term Debt	4.59	-	0.12	1.72	3.29	4.88
Long-Term Leases	0.25	0.42	0.74	1.02	1.26	1.29
Other Long-Term Liabilities	3.32	-	0.28	0.24	0.16	0.07
Total Liabilities	19.12	10.51	16.39	27.44	17.16	15.12

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	-	-	-	0	0	0
Additional Paid-In Capital	401.46	331.75	279.09	273.74	218.35	214.69
Retained Earnings	-317.73	-289.23	-250.27	-197.23	-149.31	-103.13
Comprehensive Income & Other	-	-	-	-	-0.56	-0.18
Total Common Equity	83.73	42.52	28.82	76.51	68.49	111.37
Shareholders' Equity	83.73	42.52	28.82	76.51	68.49	111.37
Total Liabilities & Equity	102.85	53.02	45.21	103.95	85.65	126.49

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	7.67	0.74	2.77	4.61	6.32	6.53
Net Cash (Debt)	88.62	48.17	35.99	91.73	72.76	82.44
Net Cash Growth	508.51%	33.85%	-60.77%	26.07%	-11.74%	-45.32%
Net Cash Per Share	62.21	62.84	65.42	178.65	231.95	264.66
Filing Date Shares Outstanding	2.87	1.37	0.56	0.55	0.53	0.31
Total Common Shares Outstanding	2.75	1.37	0.56	0.55	0.31	0.31
Working Capital	90.19	42.03	28.96	77.72	71.16	83.02
Book Value Per Share	30.42	30.99	51.18	139.85	217.64	355.56
Tangible Book Value	83.73	42.52	28.82	76.51	68.49	111.37
Tangible Book Value Per Share	30.42	30.99	51.18	139.85	217.64	355.56